- Home
- NMTC vs GDTC Comparison
NMTC vs GDTC Comparison
Compare NMTC & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMTC
- GDTC
- Stock Information
- Founded
- NMTC 2009
- GDTC 2018
- Country
- NMTC United States
- GDTC Singapore
- Employees
- NMTC N/A
- GDTC N/A
- Industry
- NMTC Medical/Dental Instruments
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- NMTC Health Care
- GDTC Health Care
- Exchange
- NMTC Nasdaq
- GDTC Nasdaq
- Market Cap
- NMTC 33.8M
- GDTC 28.0M
- IPO Year
- NMTC N/A
- GDTC 2023
- Fundamental
- Price
- NMTC $0.73
- GDTC $2.17
- Analyst Decision
- NMTC Strong Buy
- GDTC Buy
- Analyst Count
- NMTC 1
- GDTC 1
- Target Price
- NMTC $1.45
- GDTC $5.00
- AVG Volume (30 Days)
- NMTC 178.4K
- GDTC 5.7K
- Earning Date
- NMTC 08-13-2025
- GDTC 01-01-0001
- Dividend Yield
- NMTC N/A
- GDTC N/A
- EPS Growth
- NMTC N/A
- GDTC N/A
- EPS
- NMTC N/A
- GDTC N/A
- Revenue
- NMTC $5,758,777.00
- GDTC $368,838.00
- Revenue This Year
- NMTC $141.04
- GDTC $5.37
- Revenue Next Year
- NMTC $38.86
- GDTC N/A
- P/E Ratio
- NMTC N/A
- GDTC N/A
- Revenue Growth
- NMTC 54.53
- GDTC N/A
- 52 Week Low
- NMTC $0.40
- GDTC $1.20
- 52 Week High
- NMTC $1.39
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- NMTC 62.75
- GDTC 47.12
- Support Level
- NMTC $0.68
- GDTC $2.07
- Resistance Level
- NMTC $0.76
- GDTC $2.34
- Average True Range (ATR)
- NMTC 0.06
- GDTC 0.10
- MACD
- NMTC 0.01
- GDTC -0.00
- Stochastic Oscillator
- NMTC 81.78
- GDTC 41.00
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.